Table 3. Changes in IQGAP Protein Expression Level in Neoplasms‡.
| Tissue Comparison | IQGAP | Species | Method | Neoplasm | Expression Change | Refs |
|---|---|---|---|---|---|---|
| Cancer vs Normal | IQGAP1 | Human | IHC | Colorectal | + | [80] |
| MS | Squamous Cell (Head and Neck) | + | [82] | |||
| WB | Astrocytoma | + | [81] | |||
| WB | Breast | + | [23] | |||
| IQGAP2 | Human | IHC | Gastric | - | [76] | |
| Mouse | IHC/WB | Liver | - | [47] | ||
| Aggressive vs Less Aggressive Cancer† | IQGAP1 | Human | IHC | Gastric | + | [83]a |
| Glioma | + | [88]b | ||||
| Lung | + | [100]c | ||||
| Ovary | + | [84]d | ||||
| IHC/WB | Glioma | + | [87]e | |||
increased expression;
decreased expression.
Aggressive vs less aggressive cancer is defined by a decrease in long-term survivala,b,d, an increase in the likelihood of metastasisc,e.
Only published studies with primary tissue are included. Data with cultured cell lines have been omitted.
Abbreviations: IHC, immunohistochemistry; WB, western blot; MS, mass spectrometry.